日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/10/04 | 1,623 | 1,654 | 1,608 | 1,617 | -8 | -0.5% | 165,000 |
2013/10/03 | 1,622 | 1,658 | 1,622 | 1,625 | -24 | -1.5% | 227,000 |
2013/10/02 | 1,715 | 1,717 | 1,641 | 1,649 | -60 | -3.5% | 294,000 |
2013/10/01 | 1,713 | 1,717 | 1,703 | 1,709 | +17 | +1% | 224,000 |
2013/09/30 | 1,728 | 1,728 | 1,689 | 1,692 | -60 | -3.4% | 243,000 |
2013/09/27 | 1,733 | 1,782 | 1,731 | 1,752 | +30 | +1.7% | 123,000 |
2013/09/26 | 1,726 | 1,755 | 1,632 | 1,722 | -44 | -2.5% | 242,000 |
2013/09/25 | 1,756 | 1,789 | 1,748 | 1,766 | -29 | -1.6% | 106,000 |
2013/09/24 | 1,785 | 1,803 | 1,738 | 1,795 | +3 | +0.2% | 290,000 |
2013/09/20 | 1,771 | 1,798 | 1,771 | 1,792 | +21 | +1.2% | 147,000 |
2013/09/19 | 1,725 | 1,772 | 1,725 | 1,771 | +46 | +2.7% | 100,000 |
2013/09/18 | 1,754 | 1,774 | 1,702 | 1,725 | -44 | -2.5% | 399,000 |
2013/09/17 | 1,758 | 1,785 | 1,753 | 1,769 | +16 | +0.9% | 174,000 |
2013/09/13 | 1,750 | 1,764 | 1,719 | 1,753 | +6 | +0.3% | 218,000 |
2013/09/12 | 1,697 | 1,753 | 1,683 | 1,747 | +59 | +3.5% | 221,000 |
2013/09/11 | 1,713 | 1,724 | 1,684 | 1,688 | -32 | -1.9% | 105,000 |
2013/09/10 | 1,712 | 1,738 | 1,689 | 1,720 | +4 | +0.2% | 138,000 |
2013/09/09 | 1,670 | 1,728 | 1,670 | 1,716 | +61 | +3.7% | 148,000 |
2013/09/06 | 1,678 | 1,680 | 1,616 | 1,655 | -5 | -0.3% | 124,000 |
2013/09/05 | 1,692 | 1,692 | 1,655 | 1,660 | -32 | -1.9% | 58,000 |
2013/09/04 | 1,665 | 1,705 | 1,660 | 1,692 | -6 | -0.4% | 136,000 |
2013/09/03 | 1,650 | 1,700 | 1,650 | 1,698 | +72 | +4.4% | 100,000 |
2013/09/02 | 1,604 | 1,641 | 1,604 | 1,626 | -1 | -0.1% | 91,000 |
2013/08/30 | 1,645 | 1,648 | 1,608 | 1,627 | -18 | -1.1% | 173,000 |
2013/08/29 | 1,634 | 1,650 | 1,619 | 1,645 | +12 | +0.7% | 165,000 |
2013/08/28 | 1,613 | 1,650 | 1,592 | 1,633 | +13 | +0.8% | 190,000 |
2013/08/27 | 1,652 | 1,652 | 1,611 | 1,620 | -33 | -2% | 95,000 |
2013/08/26 | 1,652 | 1,666 | 1,628 | 1,653 | +2 | +0.1% | 75,000 |
2013/08/23 | 1,653 | 1,670 | 1,625 | 1,651 | +38 | +2.4% | 144,000 |
2013/08/22 | 1,631 | 1,632 | 1,600 | 1,613 | +5 | +0.3% | 88,000 |
2013/08/21 | 1,624 | 1,640 | 1,583 | 1,608 | +1 | +0.1% | 57,000 |
2013/08/20 | 1,606 | 1,652 | 1,600 | 1,607 | -15 | -0.9% | 149,000 |
2013/08/19 | 1,636 | 1,636 | 1,613 | 1,622 | +1 | +0.1% | 61,000 |
2013/08/16 | 1,637 | 1,640 | 1,619 | 1,621 | -23 | -1.4% | 93,000 |
2013/08/15 | 1,614 | 1,679 | 1,614 | 1,644 | -49 | -2.9% | 138,000 |
2013/08/14 | 1,695 | 1,695 | 1,640 | 1,693 | +38 | +2.3% | 229,000 |
2013/08/13 | 1,667 | 1,697 | 1,638 | 1,655 | +26 | +1.6% | 192,000 |
2013/08/12 | 1,630 | 1,645 | 1,615 | 1,629 | -7 | -0.4% | 112,000 |
2013/08/09 | 1,624 | 1,643 | 1,614 | 1,636 | +12 | +0.7% | 195,000 |
2013/08/08 | 1,550 | 1,658 | 1,541 | 1,624 | +10 | +0.6% | 480,000 |
2013/08/07 | 1,678 | 1,686 | 1,611 | 1,614 | -72 | -4.3% | 324,000 |
2013/08/06 | 1,724 | 1,724 | 1,654 | 1,686 | -48 | -2.8% | 251,000 |
2013/08/05 | 1,707 | 1,739 | 1,707 | 1,734 | -12 | -0.7% | 78,000 |
2013/08/02 | 1,736 | 1,746 | 1,696 | 1,746 | +50 | +2.9% | 143,000 |
2013/08/01 | 1,670 | 1,710 | 1,670 | 1,696 | +27 | +1.6% | 190,000 |
2013/07/31 | 1,696 | 1,702 | 1,666 | 1,669 | -23 | -1.4% | 128,000 |
2013/07/30 | 1,682 | 1,718 | 1,682 | 1,692 | -21 | -1.2% | 305,000 |
2013/07/29 | 1,761 | 1,770 | 1,703 | 1,713 | -74 | -4.1% | 175,000 |
2013/07/26 | 1,790 | 1,800 | 1,770 | 1,787 | -27 | -1.5% | 241,000 |
2013/07/25 | 1,816 | 1,824 | 1,805 | 1,814 | -2 | -0.1% | 269,000 |
2851~
2900
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム